These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 35655306)

  • 41. A study of the cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. A report for Children's Cancer Study Group.
    Krivit W; Anderson J; Chilcote R; Pyesmany A; Chard R; Hammond D
    Am J Pediatr Hematol Oncol; 1980; 2(3):217-21. PubMed ID: 7001942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs.
    Maguire MH; Csonka-Khalifah L
    Biochim Biophys Acta; 1987 Oct; 921(3):426-36. PubMed ID: 3117116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effective combination therapy of metastatic murine solid tumors with edatrexate and the vinca alkaloids, vinblastine, navelbine and vindesine.
    Otter GM; Sirotnak FM
    Cancer Chemother Pharmacol; 1994; 33(4):286-90. PubMed ID: 8281620
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biotechnological advancements in Catharanthus roseus (L.) G. Don.
    Das A; Sarkar S; Bhattacharyya S; Gantait S
    Appl Microbiol Biotechnol; 2020 Jun; 104(11):4811-4835. PubMed ID: 32303816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine, and vinblastine in human patients with cancer.
    Nelson RL
    Med Pediatr Oncol; 1982; 10(2):115-27. PubMed ID: 7070351
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Collateral sensitivity of a methotrexate-resistant L1210 cell line to the vinca alkaloids.
    Poppitt DG; McGown AT; Fox BW
    Cancer Chemother Pharmacol; 1984; 13(1):43-6. PubMed ID: 6733841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of snail neurons in developing quantitative ultrastructural parameters for neurotoxic side effects of Vinca antitumor agents.
    Müller LJ; Moorer-van Delft CM; Zijl R; Roubos EW
    Cancer Res; 1990 Mar; 50(6):1924-8. PubMed ID: 2407348
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics and metabolism of vinca alkaloids.
    Rahmani R; Zhou XJ
    Cancer Surv; 1993; 17():269-81. PubMed ID: 8137344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vinblastine, Vincristine and Vindesine: anti-invasive effect on MO4 mouse fibrosarcoma cells in vitro.
    Mareel MM; Storme GA; De Bruyne GK; Van Cauwenberge RM
    Eur J Cancer Clin Oncol; 1982 Feb; 18(2):199-210. PubMed ID: 7201395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells.
    Jean-Decoster C; Brichese L; Barret JM; Tollon Y; Kruczynski A; Hill BT; Wright M
    Anticancer Drugs; 1999 Jul; 10(6):537-43. PubMed ID: 10885901
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vinorelbine (Navelbine). A new semisynthetic vinca alkaloid.
    Krikorian A; Breillout F
    Onkologie; 1991 Feb; 14(1):7-12. PubMed ID: 2057177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vinca-23-oyl amino acid derivatives: as new anticancer agents (review).
    Bhushana Rao KS; Collard MP; Trouet A
    Anticancer Res; 1985; 5(4):379-86. PubMed ID: 3898995
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of vinflunine, vinorelbine, and vinblastine on centromere dynamics.
    Okouneva T; Hill BT; Wilson L; Jordan MA
    Mol Cancer Ther; 2003 May; 2(5):427-36. PubMed ID: 12748304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interactions of microtubule-active agents with nicotinic acetylcholine receptors. Relationship to their inhibition of catecholamine secretion by adrenal chromaffin cells.
    McKay DB; Aronstam RS; Schneider AS
    Mol Pharmacol; 1985 Jul; 28(1):10-6. PubMed ID: 2410767
    [TBL] [Abstract][Full Text] [Related]  

  • 55. USE OF ALKALOIDS OF VINCA ROSEA IN ACUTE LEUKEMIA.
    SAMPEY JR
    J S C Med Assoc; 1964 Dec; 60():378-80. PubMed ID: 14232424
    [No Abstract]   [Full Text] [Related]  

  • 56. PhytoNanotechnology: Enhancing Delivery of Plant Based Anti-cancer Drugs.
    Khan T; Gurav P
    Front Pharmacol; 2017; 8():1002. PubMed ID: 29479316
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Catharanthus alkaloids: pharmacognosy and biotechnology.
    van Der Heijden R; Jacobs DI; Snoeijer W; Hallard D; Verpoorte R
    Curr Med Chem; 2004 Mar; 11(5):607-28. PubMed ID: 15032608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experimental antitumor activity of 5'-nor-anhydrovinblastine navelbine.
    Maral R; Bourut C; Chenu E; Mathé G
    Cancer Lett; 1984 Feb; 22(1):49-54. PubMed ID: 6697321
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cross-resistance of vinblastine- and taxol-resistant mutants of Chinese hamster ovary cells to other anticancer drugs.
    Gupta RS
    Cancer Treat Rep; 1985 May; 69(5):515-21. PubMed ID: 2860971
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of vinorelbine in non-small-cell lung cancer. Provincial Lung Disease Site Group.
    Goss GD; Logan DM; Newman TE; Evans WK
    Cancer Prev Control; 1997; 1(1):28-38. PubMed ID: 9765724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.